Fig. 3
Quantitative changes in MRD burden after ASCT in patients with MRD ≥ 10−5 post induction across different cytogenetic subsets for (A) all patients, (B) patients who received quadruplet induction.
Fig. 3 | Blood Cancer Journal
Quantitative changes in MRD burden after ASCT in patients with MRD ≥ 10−5 post induction across different cytogenetic subsets for (A) all patients, (B) patients who received quadruplet induction.
